Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 77 entries
View as:

TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.

Phase: N/A Priority: Normal
NCT ID: NCT00736905 Org: User:
Start: 06/30/08 End: 11/30/09 Due: 11/30/10

TMC435-TiDP16-C117: The Effect of TMC435 on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01269294 Org: User:
Start: 01/31/11 End: 07/31/11 Due: 07/31/12

A Study to Assess the Long-term Safety and Tolerability of TMC114/Rtv in HIV-1 Infected Participants After Rolling-over From Other TMC114 Trials

Phase: N/A Priority: Normal
NCT ID: NCT02187107 Org: User:
Start: 01/31/05 End: 03/31/09 Due: 03/31/10

TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously

Phase: N/A Priority: Normal
NCT ID: NCT00513513 Org: User:
Start: 09/30/06 End: 10/31/07 Due: 10/31/08

PEPI-TiDP23-C104 is a First in Human Study With a Single Dose Escalation Part and a Multiple Dosing Part for Compounds TMC589337 and TMC589354.

Phase: N/A Priority: Normal
NCT ID: NCT00908414 Org: User:
Start: 05/31/09 End: 10/31/09 Due: 10/31/10

TMC125-C223: TMC125 in HIV-1 Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00081978 Org: User:
Start: 03/31/04 End: 10/31/05 Due: 10/31/06

A Study to Assess the Anti-viral Activity, Safety, Tolerability and Pharmacokinetics of TMC435350 in Participants Infected With Hepatitis C-Virus (HCV)

Phase: N/A Priority: Normal
NCT ID: NCT00812331 Org: User:
Start: 03/31/09 End: 11/30/09 Due: 11/30/10

TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir ("TMC114/r") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications.

Phase: N/A Priority: Normal
NCT ID: NCT00258557 Org: User:
Start: 09/30/05 End: 05/31/12 Due: 05/31/13

A Safety Study to Evaluate the Antiviral Activity of Darunavir in Combination With Ritonavir in HIV 1 Infected Children

Phase: N/A Priority: Normal
NCT ID: NCT00919854 Org: User:
Start: 09/30/09 End: 02/28/11 Due: 02/28/12

TMC435350-TiDP16-C105: Phase I, 3-way Crossover, Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing.

Phase: N/A Priority: Normal
NCT ID: NCT00741169 Org: User:
Start: 06/30/08 End: 12/31/08 Due: 12/31/09

TMC125-TiDP2-C188: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Effect of Multiple-dose TMC125 on Buprenorphine and Norbuprenorphine Administered in HIV-negative Patients on Stable Buprenorphine/Naloxone Maintenance Therapy.

Phase: N/A Priority: Normal
NCT ID: NCT00828815 Org: User:
Start: 03/31/09 End: 11/30/09 Due: 11/30/10

TMC435-TiDP16-C113: A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of TMC435

Phase: N/A Priority: Normal
NCT ID: NCT01046058 Org: User:
Start: 01/31/10 End: 07/31/11 Due: 07/31/12

TMC125-C227: A Phase II Randomized, Active-Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-Naive and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI Use

Phase: N/A Priority: Normal
NCT ID: NCT00225303 Org: User:
Start: 03/31/05 End: 06/30/06 Due: 06/30/07

TMC435 HPC1004 - Phase I Study Investigating the Pharmacokinetics of TMC435 in Healthy Chinese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01224197 Org: User:
Start: 10/31/10 End: 01/31/11 Due: 01/31/12

TMC435350-TiDP16-C109: A Safety Study for TMC435350 in an Oral Solution Containing Either 100, 200 or 400 mg Equivalent of TMC435350 or Placebo in Healthy Japanese Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00752544 Org: User:
Start: 08/31/08 End: 11/30/08 Due: 11/30/09

TMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278

Phase: N/A Priority: Normal
NCT ID: NCT01031589 Org: User:
Start: 01/31/10 End: 07/31/11 Due: 07/31/12

TMC435-TiDP16-C123 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents Efavirenz and Raltegravir

Phase: N/A Priority: Normal
NCT ID: NCT01241773 Org: User:
Start: 10/31/10 End: 04/30/11 Due: 04/30/12

A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00838162 Org: User:
Start: 06/30/09 End: 02/28/11 Due: 02/28/12

TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.

Phase: N/A Priority: Normal
NCT ID: NCT00739622 Org: User:
Start: 07/31/08 End: 12/31/08 Due: 12/31/09

TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens.

Phase: N/A Priority: Normal
NCT ID: NCT00245739 Org: User:
Start: - End: - Due: -

TMC649128HPC1001 - First In-human Trial to Examine Safety, Tolerability, and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses of TMC649128 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01288677 Org: User:
Start: 01/31/11 End: 06/30/11 Due: 06/30/12

TMC435-TiDP16-C121: A Study Comparing 2 Tablet Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Effect of Food on Blood Levels of TMC435

Phase: N/A Priority: Normal
NCT ID: NCT01022125 Org: User:
Start: 01/31/10 End: 04/30/10 Due: 04/30/11

TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00071097 Org: User:
Start: 10/31/03 End: 11/30/07 Due: 11/30/08

TMC114-TiDP3-C181: Study to Assess the Pharmacokinetics of Darunavir (DRV) With Different Doses of Ritonavir in Healthy Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT00744887 Org: User:
Start: 08/31/08 End: 12/31/08 Due: 12/31/09

TMC278-TiDP6-C154: Evaluation of the Possible Influence of Omeprazole Intake - and the pH Increase in the Stomach Triggered by Omeprazole Intake - on the Blood Levels of TMC278 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01001247 Org: User:
Start: 01/31/10 End: 04/30/10 Due: 04/30/11